Edible vaccines: current status and future.
Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and socioculturally readily acceptable vaccine delivery system, especially for the poor developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins. Introduced as a concept about a decade ago, it has become a reality today. A variety of delivery systems have been developed. Initially thought to be useful only for preventing infectious diseases, it has also found application in prevention of autoimmune diseases, birth control, cancer therapy, etc. Edible vaccines are currently being developed for a number of human and animal diseases. There is growing acceptance of transgenic crops in both industrial and developing countries. Resistance to genetically modified foods may affect the future of edible vaccines. They have passed the major hurdles in the path of an emerging vaccine technology. Various technical obstacles, regulatory and non-scientific challenges, though all seem surmountable, need to be overcome. This review attempts to discuss the current status and future of this new preventive modality.
Lal
P
P
Department of Microbiology, University College of Medical Sciences, Guru Teg Bahadur Hospital, New Delhi - 110 095, India.
Ramachandran
V G
VG
Goyal
R
R
Sharma
R
R
D000818:Animals; D003140:Communicable Disease Control / Q000379:methods; D003267:Contraception / Q000379:methods; D003906:Developing Countries; D006801:Humans; D006967:Hypersensitivity / Q000517:prevention & control; D009369:Neoplasms / Q000628:therapy; D022462:Vaccines, Edible
D022462:Vaccines, Edible